Collaboration between Emergency and Immunology departments is vital to achieving standard of care in anaphylaxis management. While Emergency Medicine physicians are proficient in the acute treatment of anaphylaxis, consultation with a specialist Immunology service helps ensure comprehensive discharge planning. Further studies on barriers to referral are needed.
Method: All patients who had GA allergy testing at RMH between 1 July 2015 and 22 May 2017 were identified and a retrospective audit was completed. GA skin testing panels were standardised and comprised of neuromuscular blocking agents (NMBAs) (suxamethonium, rocuronium, vecuronium, pancuronium, atracurium, cisatracurium) , sedatives (propofol, midazolam), opiates (morphine, fentanyl, alfentanil, remifentanil), cefazolin, latex and chlorhexidine. If patients had not been exposed to a class of drug peri-operatively, the entire class was excluded from testing. All drugs were tested at recommended maximum non-irritant concentrations. 
Results

P15 DRUG REPORTING ACCURACY AND COMPLETENESS IS DEPENDENT ON THOSE WHO ARE INVESTED IN NEGATIVE OUTCOMES OF ADVERSE DRUG REACTIONS
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It is widely observed that drug allergy documentation is often performed poorly. We hypothesised that there are different levels of compliance with drug allergy reporting in different modes of documentation within the same patient's case notes.
Methods: 76 medical records were from patients that were post-anaesthetic elective/emergency, medical/surgical inpatients in October 2016 were randomly audited. Allergy details were extracted from the standard medication charts, the Flinders Medical Centre Alert Sheet and Anaesthetic charts for these patients. Each were assessed for compliance with the Australian Commission on Safety and Quality in Health Care (ACSQHC) Standard 4 and the Clinical Procedure: Adverse Drug Reaction and Allergies Reporting Procedure (Flinders Medical Centre, 30 July 2014). Those that were deemed to be compliant had the name of drug (or documentation of 'no allergy'), information describing drug reaction and details of the person recording the reaction.
Results: Anaesthetic charts were 79% compliant with standards. National Medication Charts (NIMC) 51% compliance and Alert Sheet reporting at 9% had the lowest compliance rates. In cases where information was incomplete, some had only drug listed, without reaction details or name of person documenting.
Conclusions: Drug reporting can be performed by health professionals (HP's) with accuracy, care and completeness. It appears that documentation appears to be of higher quality for those HP with a greater investment in direct administration of medication and or related to specialty knowledge of drug allergy, such as the risk of intra-operative anaphylaxis and reporting by anaesthetists. It is hypothesised that persons who are not authorised to document in the notes such as nursing staff, complete the relevant information as a way of preventing medication errors, but omit their name and title due to legal reasons.
P16 PENICILLIN ALLERGY LABELLING ON THE MEDICALERT
® ID
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Aim: To improve understanding of the penicillin allergy label on the MedicAlert ® ID.
Methods:
The MedicAlert database of active subscribers was used to identify those with the generic term 'penicillin' on their ID. A subset of members with a registered email address were randomly chosen and emailed by MedicAlert Foundation. Information collected included details of the antibiotic, the reaction, application for MedicAlert and willingness for allergy testing.
Results: Of 131 respondents, 27 (20%) were male, average (AESD) age 61 (AE16.4) years. The index penicillin was reported as amoxicillin in 12 (9%) cases, a cephalosporin in 2 (1.5%) and unknown in the majority (82%, n = 108). The index reactions occurred an average of 31.6 years ago with 82% (n = 108) being >10 years ago and 10.6% (n = 14) of index reactions at less than ≤5 years of age. 50 (38%) patients did not report features to suggest a severe reaction, such as anaphylaxis or Stevens-Johnson syndrome. 44 avoid cephalosporins but 45 had tolerated cephalexin. 22 patients reported tolerance to amoxicillin despite a penicillin allergy label. The majority of patients relied on GP (79) or self (44) for assistance with MedicAlert ID wording. 62% would be interested in testing for penicillin allergy, but 25% of the overall sample would not change their MedicAlert if found not to be allergic.
Conclusions: A substantial proportion did not report features to suggest a severe allergic reaction and would be appropriate for drug challenge and potential de-labeling. A small but significant subset reported high-risk features such as anaphylaxis or severe cutaneous reaction. A detailed history at the time of ordering a MedicAlert could identify those at lower risk who might benefit from further evaluation, whereas more informative wording on the MedicAlert could be used to signify those at high risk of a serious reaction from penicillin exposure. 
